Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study
about
Cross-validation of a mass spectrometric-based method for the therapeutic drug monitoring of irinotecan: implementation of matrix-assisted laser desorption/ionization mass spectrometry in pharmacokinetic measurements.Mass spectrometry in the pharmacokinetic studies of anticancer natural products.Vitamin D Enhances the Efficacy of Irinotecan through miR-627-Mediated Inhibition of Intratumoral Drug Metabolism.Development and validation of an UPLC-MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in rats.Crypt Organoid Culture as an in Vitro Model in Drug Metabolism and Cytotoxicity Studies.A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study.
P2860
Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Development and validation of ...... clinical pharmacokinetic study
@ast
Development and validation of ...... clinical pharmacokinetic study
@en
Development and validation of ...... clinical pharmacokinetic study
@nl
type
label
Development and validation of ...... clinical pharmacokinetic study
@ast
Development and validation of ...... clinical pharmacokinetic study
@en
Development and validation of ...... clinical pharmacokinetic study
@nl
prefLabel
Development and validation of ...... clinical pharmacokinetic study
@ast
Development and validation of ...... clinical pharmacokinetic study
@en
Development and validation of ...... clinical pharmacokinetic study
@nl
P2860
P1433
P1476
Development and validation of ...... clinical pharmacokinetic study
@en
P2093
Elena Marangon
Elisa Mazzega
P2860
P304
P356
10.1371/JOURNAL.PONE.0118194
P407
P577
2015-01-01T00:00:00Z